Sadik, C. D., Langan, E. A., Grätz, V., Zillikens, D., & Terheyden, P. (2019). Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid. Front Immunol.
Chicago-tyylinen lähdeviittausSadik, Christian D., Ewan A. Langan, Victoria Grätz, Detlef Zillikens, ja Patrick Terheyden. "Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid." Front Immunol 2019.
MLA-viiteSadik, Christian D., et al. "Checkpoint Inhibition May Trigger the Rare Variant of Anti-LAD-1 IgG-Positive, Anti-BP180 NC16A IgG-Negative Bullous Pemphigoid." Front Immunol 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.